| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |